title: Folate receptor alpha (FRA) expression in breast cancer: identification of a new molecular subtype and association with triple negative disease.
abstract: Given that several targeted therapies directed towards folate receptor alpha (FRA) are in late stage clinical development, the sensitive and robust detection of FRA in tissues is of paramount importance relative to patient selection, prognosis and prediction. In the present study we undertook an immunohistochemical evaluation of expression of FRA in breast cancer samples using formalin-fixed, paraffin-embedded (FFPE) tissues, primarily invasive ductal carcinomas, using a newly described monoclonal antibody, 26B3. Samples assessed included both tissue microarrays (TMA) and whole tissue sections from archival tissue blocks. Normal breast shows a highly restricted expression of FRA to luminal membrane staining of secretory ductal cells, consistent with FRA secretion into milk. In early stage (stages I-III) invasive ductal carcinomas, FRA staining was observed in approximately 30% of all samples, independent of molecular subtype (estrogen receptor (ER)/progesterone receptor (PR)/human epidermal growth factor receptor type 2 (Her2)). However, FRA expression was shown to associate with ER/PR negative tumors relative to ER/PR positive tumors (p = 0.012) and perhaps more importantly, with triple negative breast cancers (TNBC; p < 0.0001). FRA immunoreactivity was also shown to be retained in stage IV metastatic breast cancer samples from diverse anatomic sites including lymph node and bone. In metastatic breast cancer, FRA was shown to be expressed in 86% of TNBC patients. Taken together, these data suggest that FRA expressing breast cancer represents a novel molecular subtype and, further, may represent a new therapeutic target for this devastating disease.
authors: Department of Diagnostics Development, Morphotek, Inc, 210 Welsh Pool Road, Exton, PA 19341 USA.
authors: Daniel J
authors: DJ
authors: O'Shannessy
authors: Elizabeth B
authors: EB
authors: Somers
authors: Julia
authors: J
authors: Maltzman
authors: Robert
authors: R
authors: Smale
authors: Yao-Shi
authors: YS
authors: Fu
keywords: Breast cancer; FRA; Folate receptor alpha; IHC; Immunohistochemistry; Triple negative breast cancer
references: Cancer Detect Prev. 1985;8(1-2):71-5
references: 4064054
references: Oncotarget. 2012 Apr;3(4):414-25
references: 22547449
references: Clin Cancer Res. 2010 Nov 1;16(21):5288-95
references: 20855460
references: J Thorac Cardiovasc Surg. 2001 Feb;121(2):225-33
references: 11174727
references: Int J Cancer. 2006 Jul 15;119(2):243-50
references: 16453285
references: Ann Surg Oncol. 2008 Mar;15(3):889-99
references: 18181001
references: Int J Cancer Suppl. 1994;8:89-95
references: 8194901
references: Adv Drug Deliv Rev. 2004 Apr 29;56(8):1067-84
references: 15094207
references: Cancer Res. 2003 Jun 1;63(11):2820-8
references: 12782587
references: Int J Cancer. 2007 Sep 1;121(5):938-42
references: 17487842
references: Int J Cancer. 1997 Apr 22;74(2):193-8
references: 9133455
references: Cancer Epidemiol Biomarkers Prev. 1999 Sep;8(9):775-82
references: 10498396
references: Int J Cancer. 1991 Jan 21;47(2):163-9
references: 1988361
references: Cancer Immun. 2007 Mar 09;7:6
references: 17346028
references: Curr Opin Chem Biol. 2009 Jun;13(3):256-62
references: 19419901
references: Cancer. 2007 May 1;109(9):1721-8
references: 17387718
references: CA Cancer J Clin. 2012 Jan-Feb;62(1):10-29
references: 22237781
references: Int J Cancer. 1998 Apr 17;79(2):121-6
references: 9583724
references: Cancer. 1994 May 1;73(9):2432-43
references: 7513252
references: J Clin Oncol. 2012 May 20;30(15):1879-87
references: 22454417
references: Oncotarget. 2011 Dec;2(12):1227-43
references: 22204844
references: Cancer Res. 1992 Jun 15;52(12):3396-401
references: 1596899
references: Ann Oncol. 2012 Sep;23(9):2223-2234
references: 22517820
references: Curr Opin Investig Drugs. 2010 Dec;11(12):1424-33
references: 21154124
references: J Clin Invest. 1992 Sep;90(3):840-7
references: 1387884
references: Anal Biochem. 2005 Mar 15;338(2):284-93
references: 15745749
references: Cancer Res. 1992 Dec 1;52(23):6708-11
references: 1330299
references: Hum Pathol. 2008 Apr;39(4):498-505
references: 18342661
references: Biochemistry. 2009 Sep 1;48(34):8249-60
references: 19639961
references: Expert Opin Biol Ther. 2010 Mar;10(3):431-7
references: 20092424